Association of lamivudine resistance in recurrent hepatitis B after liver transplantation with advanced hepatic fibrosis

Transplantation

Volumn 68, Issue 2, 1999, Pages 232-236

  Ben Ari, Ziv ^a,b   Pappo, Orit ^a   Zemel, Romy ^b   Mor, Eitan ^a   Tur Kaspa, Ran ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; FAMCICLOVIR; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; TYROSINE; VIRUS DNA;

ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; GENE LOCUS; GENE MUTATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; SEQUENCE ANALYSIS; VIRUS GENE; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; DNA, VIRAL; DRUG RESISTANCE, MICROBIAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME;

EID: 0033609520     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199907270-00012     Document Type: Article

References (19)

1. Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991; 13: 619.
2. Samuel D, Muller R, Alexander G, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329: 1842.
3. O'Grady JG, Smith HM, Davies SE, et al. Hepatitis B virus reinfection after orthotopic liver transplantation: serological and clinical implications. J Hepatol 1992; 14: 104.
4. Muller R, Gubernatis G, Farle M, et al. Liver transplantation in HBs antigen (HBsAg) carriers: prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 1991; 13: 90.
5. Davies SE, Portman BC, O'Grady JG, et al. Hepatic histological findings after liver transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991; 13: 150.
6. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333: 1657.
7. Grellier L, Mutimer D, Ahmed M, et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996; 384: 1212.
8. Bain VG, Kneteman NM, Ma MM, et al. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Transplantation 1996; 62: 1456.
9. Ben-Ari, Z, Shmueli D, Mor E, Shapira Z, Tur-Kaspa R. Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation. Transplantation 1997; 63: 393.
10. Honkoop P, Niesters HGM, de Man RAM, Osterhaus ADME, Schalm SW. Lamivudine resistance in immunocompetent chronic hepatitis B: incidence and patterns. J Hepatol 1997; 26: 1393.
11. Ling R, Mutimer D, Ahmed M, et al. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 1996; 24: 711.
12. Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DLJ. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 1996; 24: 714.
13. Bartholomew MM, Jansen RW, Jeffers LJ, et al. Hepatitis B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 1997; 349: 20.
14. Honkoop P, de Mam RA, Zondervan PE, Schalm SW. Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine. Liver 1997; 17: 103.
15. Heathcote J, Schalm SW, Clanciara J, et al. Lamivudine and intron: a combination treatment in patients with chronic hepatitis B infection. J Hepatol 1998; 28 (suppl): 43.
16. Lai CL, Liaw YF, Leung NWY, et al. Twelve months of lamivudine (100 mg od) therapy improves liver histology: results of a placebo controlled multicenter study in Asia. J Hepatol 1997; 26 (suppl): 79.
17. Perrillo R, Ratela J, Martin P, et al. Long term lamivudine therapy of patients with recurrent hepatitis B post liver transplantation. Hepatology 1997; 26: 177A.
18. Blum HE. Variants of hepatitis B, C and D viruses: molecular biology and clinical significance. Digestion 1995; 56: 85.
19. Girones R, Miller RH. Mutation rate of the hepadnavirus genome. Virology 1989; 170: 595.